Literature DB >> 2054233

Stimulation by 1,25-dihydroxyvitamin D3 of in vitro mineralization induced by osteoblast-like MC3T3-E1 cells.

T Matsumoto1, C Igarashi, Y Takeuchi, S Harada, T Kikuchi, H Yamato, E Ogata.   

Abstract

Although vitamin D is essential for mineralization of bone, it is as yet unclear whether vitamin D has a direct stimulatory effect on the bone mineralization process. In the present study, the effect of 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] on in vitro mineralization mediated by osteoblast-like MC3T3-E1 cells was examined. MC3T3-E1 cells continued to grow after they reached confluency, and DNA content and alkaline phosphatase activity increased linearly until about 16 days of culture, whereas 45Ca accumulation into cell and matrix layer remained low. After this period, DNA content plateaued, and 45Ca accumulation increased sharply. Histological examination by von Kossa staining revealed that calcium was accumulated into extracellular matrix. In addition, needle-shaped mineral crystals similar to hydroxyapatite crystals could be demonstrated in between collagen fibrils by electron microscopy. Thus, MC3T3-E1 cells differentiate in vitro into cells with osteoblastic phenotype and exhibit mineralization. When MC3T3-E1 cells were treated with 1,25(OH)2D3 at this stage of culture, there was a dose-dependent stimulation of 45Ca accumulation by 1,25(OH)2D3, and a significant stimulation of 45Ca accumulation was observed with 3 x 10(-10) M 1,25(OH)2D3. Although 1,25(OH)2D3 enhanced alkaline phosphatase activity and collagen synthesis at the early phase of culture, it did not affect any of these parameters at the late phase when 1,25(OH)2D3 stimulated mineralization. Neither 24,25-dihydroxyvitamin D3 nor human PTH(1-34) affected mineralization in the presence or absence of 1,25(OH)2D3. These results demonstrate that 1,25(OH)2D3 stimulates matrix mineralization induced by osteoblastic MC3T3-E1 cells, and are consistent with the possibility that 1,25(OH)2D3 has a direct stimulatory effect on bone mineralization process.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2054233     DOI: 10.1016/8756-3282(91)90051-j

Source DB:  PubMed          Journal:  Bone        ISSN: 1873-2763            Impact factor:   4.398


  28 in total

1.  Vitamin K2 promotes 1alpha,25(OH)2 vitamin D3-induced mineralization in human periosteal osteoblasts.

Authors:  Y Koshihara; K Hoshi; H Ishibashi; M Shiraki
Journal:  Calcif Tissue Int       Date:  1996-12       Impact factor: 4.333

2.  Examination of mineralized nodule formation in living osteoblastic cultures using fluorescent dyes.

Authors:  Yu-Hsiung Wang; Yaling Liu; Peter Maye; David W Rowe
Journal:  Biotechnol Prog       Date:  2006 Nov-Dec

3.  Vitamin D endocrine system and osteoblasts.

Authors:  Marjolein van Driel; Johannes P T M van Leeuwen
Journal:  Bonekey Rep       Date:  2014-02-05

4.  Stimulation by bone sialoprotein of calcification in osteoblast-like MC3T3-E1 cells.

Authors:  H Y Zhou; H Takita; R Fujisawa; M Mizuno; Y Kuboki
Journal:  Calcif Tissue Int       Date:  1995-05       Impact factor: 4.333

5.  Elongation of the side chain of analogs of 1 alpha,25-dihydroxyvitamin D3 prevents osteopenia in a rat model.

Authors:  M Harada; T Takamura; S Kajita-Kondo; A Kozakai; T Miyahara; H Kozuka; N Ikekawa; S Higuchi; S Otomo
Journal:  Calcif Tissue Int       Date:  1995-03       Impact factor: 4.333

6.  17 beta-estradiol inhibits interleukin-6 production by bone marrow-derived stromal cells and osteoblasts in vitro: a potential mechanism for the antiosteoporotic effect of estrogens.

Authors:  G Girasole; R L Jilka; G Passeri; S Boswell; G Boder; D C Williams; S C Manolagas
Journal:  J Clin Invest       Date:  1992-03       Impact factor: 14.808

7.  Normal and osteoporotic human osteoblast behaviour after 1,25-dihydroxy-vitamin D(3) stimulation.

Authors:  N Maruotti; A Corrado; M Grano; S Colucci; F P Cantatore
Journal:  Rheumatol Int       Date:  2008-11-07       Impact factor: 2.631

8.  Activating transcription factor 4, an ER stress mediator, is required for, but excessive ER stress suppresses osteoblastogenesis by bortezomib.

Authors:  Shingen Nakamura; Hirokazu Miki; Shinsuke Kido; Ayako Nakano; Masahiro Hiasa; Asuka Oda; Hiroe Amou; Keiichiro Watanabe; Takeshi Harada; Shiro Fujii; Kyoko Takeuchi; Kumiko Kagawa; Shuji Ozaki; Toshio Matsumoto; Masahiro Abe
Journal:  Int J Hematol       Date:  2013-05-25       Impact factor: 2.490

9.  A novel synthetic vitamin D analogue, 2 beta-(3-hydroxypropoxy)1 alpha, 25-dihydroxyvitamin D3 (ED-71), increases bone mass by stimulating the bone formation in normal and ovariectomized rats.

Authors:  H Tsurukami; T Nakamura; K Suzuki; K Sato; Y Higuchi; Y Nishii
Journal:  Calcif Tissue Int       Date:  1994-02       Impact factor: 4.333

10.  p73 is essential for vitamin D-mediated osteoblastic differentiation.

Authors:  R Kommagani; A Whitlatch; M K Leonard; M P Kadakia
Journal:  Cell Death Differ       Date:  2009-09-25       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.